Chaves A A, Weinstein D M, Bauer J A
Divison of Pharmacology/College of Pharmacy, OSU Heart and Lung Research Institute, The Ohio State University, Columbus 43210, USA.
Life Sci. 2001 Jun 1;69(2):213-22. doi: 10.1016/s0024-3205(01)01123-7.
Transgenic murine models of cardiovascular disease offer great potential insights regarding mechanisms of human disease, but efficient and reliable methods for phenotype evaluation are necessary. We employed non-invasive echocardiography to evaluate hemodynamic parameters in mice, and evaluated statistical reliability of these parameters with respect to anesthesia regimen. Male CF-1 mice received inhaled halothane (0.25-0.75% in 95% O2) or ketamine/xylazine (80/10 mg/kg i.p.) and 2-dimensional, M-mode, and Doppler ultrasound imaging were used to assess cardiac contractility and aortic flow velocities. Halothane was more convenient and reliable with respect to rate of induction, reversal, and control of anesthetic depth. At comparable levels of anesthesia, ketamine/xylazine produced significant reductions in heart rate (308 +/- 14 vs. 501 +/- 14 bpm, p<0.001), left ventricular fractional shortening (41.7 +/- 1.3 vs. 49.3 +/- 1.0%, p<0.001), and cardiac output (7.6 +/- 0.5 vs. 11.5 +/- 0.6 ml/min, p<0.001) when compared to halothane inhalation. No change in stroke volume or peak aortic velocity was observed. Correlation analyses revealed highly significant positive relationships between heart rate and fractional shortening (r=0.61, p<0.002) and cardiac output (r=0.88, p<0.001) but no relation to stroke volume or aortic velocity. Variability of intra-animal and intragroup parameter estimation were frequently 2-fold larger for ketamine/xylazine anesthesia vs. halothane. Statistical power analysis showed the increased measurement error for ketamine/xylazine leads to much larger numbers of mice/group to achieve identical statistical sensitivity. These data further illustrate the feasibility of echocardiography for rapid, non-invasive cardiovascular assessment in mice. However, several obtainable parameters are highly sensitive to both heart rate and anesthetic used and the choice and control of anesthetic are critical for physiologically relevant performance parameters and maximal ability to detect statistical differences among groups. Thus, for these non-invasive studies, inhalation anesthesia with agents such as halothane is superior to anesthesia induced by ketamine/xylazine administration.
心血管疾病的转基因小鼠模型为了解人类疾病机制提供了巨大的潜在见解,但需要高效可靠的表型评估方法。我们采用非侵入性超声心动图评估小鼠的血流动力学参数,并评估这些参数相对于麻醉方案的统计可靠性。雄性CF-1小鼠接受吸入氟烷(在95%氧气中为0.25 - 0.75%)或氯胺酮/赛拉嗪(80/10毫克/千克腹腔注射),并使用二维、M型和多普勒超声成像来评估心脏收缩力和主动脉流速。氟烷在诱导速度、苏醒速度和麻醉深度控制方面更方便可靠。在可比的麻醉水平下,与吸入氟烷相比,氯胺酮/赛拉嗪导致心率显著降低(308±14对501±14次/分钟,p<0.001)、左心室缩短分数显著降低(41.7±1.3对49.3±1.0%,p<0.001)和心输出量显著降低(7.6±0.5对11.5±0.6毫升/分钟,p<0.001)。未观察到每搏输出量或主动脉峰值流速的变化。相关性分析显示心率与缩短分数(r = 0.61,p<0.002)和心输出量(r = 0.88,p<0.001)之间存在高度显著的正相关,但与每搏输出量或主动脉流速无关。与氟烷相比,氯胺酮/赛拉嗪麻醉时动物内和组内参数估计的变异性通常大2倍。统计功效分析表明,氯胺酮/赛拉嗪测量误差的增加导致每组需要更多数量的小鼠才能达到相同的统计灵敏度。这些数据进一步说明了超声心动图在小鼠中进行快速、非侵入性心血管评估的可行性。然而,几个可获得的参数对心率和所用麻醉剂都高度敏感,麻醉剂的选择和控制对于生理相关的性能参数以及检测组间统计差异的最大能力至关重要。因此,对于这些非侵入性研究,使用氟烷等药物的吸入麻醉优于氯胺酮/赛拉嗪诱导麻醉。